About QBRI | Hamad Bin Khalifa University

Qatar Biomedical Research Institute (QBRI) is a leading research institute under Hamad Bin Khalifa University (HBKU). The institute addresses the Qatar National Health priorities outlined in the Qatar National Research Strategy through its dedicated research centers – the Translational Cancer and Immunity Center (TCIC), Diabetes Research Center (DRC) and Neurological Disorders Research Center (NDRC).

 

Brochure


QBRI was founded in 2012 as a national center of excellence and a global hub for biomedical and translational research. The institute works to improve and transform healthcare in Qatar through discoveries in the prevention, diagnosis, and treatment of diseases, affecting the people of Qatar and populations across the region.

The national center of excellence boasts seven state-of-the-art core facilities including stem cells, genomics, proteomics, structural biology, flow cytometry, advanced microscopy and imaging, and clinical research core.

QBRI works toward the development of novel biomarkers, and diagnostic and therapeutic solutions to facilitate early diagnosis, treatment, and management of select diseases and improve personalized medicine and healthcare.

As a global hub for biomedical and translational research, QBRI continually partners with renowned national and international institutions, enabling the institute to transcend geographical borders and challenges. Above all, QBRI is dedicated to making meaningful contributions to the biomedical field by attracting outstanding scientists, who conduct research in state-of-the-art laboratories featuring a truly unique core technology platform. 

The institute is also committed to supporting the next generation of scientists to become highly skilled researchers through mentoring, advanced scientific and research training opportunities and career guidance.